Catharina Hospital
Eindhoven, Netherlands
NCT Number: NCT05209555
There is lack of attention to preoperative cognitive function and delirium in elderly who underwent surgery. The investigators are investigating different tools that can help to screen for cognitive dysfunction and delirium in the future.
Looking for future studies?
Notify Me65 year–120 year
All sexes
Observational
Eindhoven, Netherlands
Background of the study:
The mean age of surgical patients is rising worldwide and this is associated with more multi-morbidity. Especially geriatric patients who undergo surgery have a higher risk to develop Postoperative Cognitive Dysfunction or a Postoperative Delirium, which leads to higher morbidity and mortality after surgery and this leads to higher healthcare costs.
A delirium is an acutely disturbed state of mind characterized by restlessness, illusions, and incoherence, occurring in intoxication, fever, and other disorders and can fluctuate over time. The hypoactive delirium, the most common type of delirium, is hard to recognize compared to the active delirium that is expressed by restlessness and agitation.
Postoperative cognitive dysfunction is defined as a new cognitive impairment arising after a surgical procedure. Its diagnosis requires both pre- and postoperative psychometric testing. Its manifestations are subtle and manifold, depending on the particular cognitive domains that are affected, and therefore hard to recognize too.
To assess preoperative cognitive function in large groups of patients, it's needed to have a simple and quick tool to screen. In this study, the investigators use the BAMCOG, which is a tool with 3 short games played on a tablet that can provide information about cognitive functioning. When writing this new study protocol, a validation study in which the BAMCOG is validated against the MoCA is running.
Beside the BAMCOG, another instrument will be investigated. The DeltaScan is an EEG delta waves measurement to identify patients with a (hypoactive) delirium. Delta waves are slow brainwaves that have been seen in sedated patients and even inpatients with an active or hypoactive delirium. A study of Kimchi et al. studied whether routine clinical EEG findings, including slowing, are correlated with delirium severity in a heterogeneous population with various causes of altered mental status and found that generalized slowing on routine clinical EEG strongly correlates with delirium and may be a valuable biomarker for delirium severity (OR 7.4, 95% CI 3.8-14.4).
A lot remains unclear about the biological mechanisms in the development of a delirium after surgery, although in literature are directions that inflammatory reactions and the neuro-endocrine system play an important role. That is the reason for investigating the relation between cortisol levels in blood, saliva and sweat and the development of postoperative acute encephalopathy.
Objective of the study:
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
MoCA test to identify Mild Cognitive Impairment
Three games, compared to the MoCA to identify Mild Cognitive Impairment
EEG to detect acute encephalopathy
To collect saliva for cortisol analysis
To collect sweat for cortisol analysis
Time frame: BAMCOG and DeltaScan - preoperative 1 day, postoperative day 1, 3, 7.
Time frame: MoCA - preoperative 1 day, postoperative day 1, 3, 7
Time frame: Preoperative at home and postoperative day 1
Catharina Ziekenhuis Eindhoven
Other
Observational Study on the Predictive Value of the BAMCOG and Cortisol Levels for the Incidence of Postoperative Delirium/Postoperative Acute Encephalopathy Measured by the MoCA and the DeltaScan in Patients Who Undergo Aortic Valve Replacement Surgery
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06567574
Cognition Disorders, Cognitive Dysfunction
Palo Alto, California, United States
View Trial DetailsNCT05114876
Cognition Disorders, Cognitive Decline
Toronto, Ontario, Canada
View Trial DetailsNCT06519890
Cognition Disorders, Cognitive Dysfunction
Palo Alto, California, United States
View Trial DetailsNCT03147937
Autoimmune Diseases, Cognition Disorders
Toronto, Ontario, Canada
View Trial Details